Mid-stage data on Allakos' lirentelimab published
Investor Relations IR for NASDAQ and New York Stock Exchange NYSE Listed Companies OTC Tip Reporter
Mid-stage data on Allakos' lirentelimab published in New England Journal of Medicine
OTC Tip Reporter is currently taking on new clients that are looking for more coverage for their companies that are trading on the NASDAQ and NYSE. You may visit us online at https://www.otctipreporter.com/ to read our disclaimer and about our media packages and marketing services to NASDAQ and NYSE trading companies. Get in touch with us by calling 1-800-850-9305.
-
OTC Tip Reporter Reports Trending Market News And Assists NASDAQ and NYSE Companies with Improving Exposure Online Through Media Packages